CF-602

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCF-602
Drug Alias NameCF-602
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeiden UniversityNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesCan-Fite Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A